J. Cui

Efficacy and safety of geptanolimab (GB226) for relapsed or refractory peripheral T cell lymphoma: an open-label phase 2 study (Gxplore-002)

Z. Ge, Yuankai Shi, Liping Xie, 2021, Journal of Hematology & Oncology.

Parameter optimal selection during pediatric 18F-FDG PET/CT examination

Ling Yuan, Rongrong Tian, Hongyu Zhang, 2014 .